These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2725060)

  • 41. Antileukemic activity of recombinant humanized M195-gelonin immunotoxin in nude mice.
    Xu Y; Xu Q; Rosenblum MG; Scheinberg DA
    Leukemia; 1996 Feb; 10(2):321-6. PubMed ID: 8637241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibody dependent cellular cytotoxicity and complement mediated cytotoxicity on leukemic cells mediated by anti K562 monoclonal antibodies.
    Tatake RJ; Maniar HS; Chiplunkar SV; Somasundaram R; Amin MK; Saikia T; Gangal SG
    J Clin Lab Immunol; 1990 Feb; 31(2):87-91. PubMed ID: 1966990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of nonspecific cross-reacting antigen species in myeloid leukemic patients and healthy subjects.
    Noworolska A; Harłozińska A; Buchegger F; Lawińska B; Richter R
    Blut; 1989 Feb; 58(2):69-73. PubMed ID: 2920218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
    Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors.
    Shimoda K; Okamura S; Harada N; Ikematsu W; Kondo S; Kawasaki C; Tanaka T; Etou T; Akashi K; Okamura T
    Cancer Res; 1992 Jun; 52(11):3052-5. PubMed ID: 1534271
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of monoclonal antibodies for the identification and classification of acute myeloid leukemias.
    Drexler HG; Minowada J
    Leuk Res; 1986; 10(3):279-90. PubMed ID: 3512924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myeloid lineage specificity and high sensitivity of monoclonal antibody GM 58/8 proves its usefulness as a diagnostic reagent in acute leukemia.
    Das Gupta A; Dhond SR; Barbhaya SA; Advani SH
    Am J Hematol; 1987 Jun; 25(2):125-30. PubMed ID: 3300282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reactivity pattern of 'myeloid monoclonal antibodies' with emphasis on MCS-2.
    Drexler HG; Sagawa K; Menon M; Minowada J
    Leuk Res; 1986; 10(1):17-23. PubMed ID: 3456072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
    Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
    Leuk Lymphoma; 2001 Aug; 42(4):675-82. PubMed ID: 11697497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia.
    Caron PC; Lai LT; Scheinberg DA
    Clin Cancer Res; 1995 Jan; 1(1):63-70. PubMed ID: 9815888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
    Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
    Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunophenotype of clonogenic cells in myeloid leukaemia.
    Kabral A; Bradstock KF; Grimsley P; Favaloro EJ
    Leuk Res; 1988; 12(1):51-9. PubMed ID: 3162752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.
    Caron PC; Dumont L; Scheinberg DA
    Clin Cancer Res; 1998 Jun; 4(6):1421-8. PubMed ID: 9626458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Study of leukemic colony-forming units (CFU-L) in non-lymphoblastic malignant hemopathies].
    Almeida J; Cañizo C; Sánchez IJ; Nieto MJ; San Miguel JF; González M; Orfao A
    Sangre (Barc); 1989 Dec; 34(6):467-70. PubMed ID: 2629122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
    Baryshnikov AIu
    Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysis.
    Drexler HG; Menon M; Gaedicke G; Minowada J
    Cancer Immunol Immunother; 1986; 21(3):188-92. PubMed ID: 3457629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences.
    Kersemans V; Cornelissen B; Minden MD; Brandwein J; Reilly RM
    J Nucl Med; 2008 Sep; 49(9):1546-54. PubMed ID: 18703602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia.
    Schwarzinger I; Valent P; Köller U; Marosi C; Schneider B; Haas O; Knapp W; Lechner K; Bettelheim P
    J Clin Oncol; 1990 Mar; 8(3):423-30. PubMed ID: 2307987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoclonal antibodies reactive with human myeloid leukaemia cells.
    Ball ED; Fanger MW
    Clin Exp Immunol; 1982 Jun; 48(3):655-65. PubMed ID: 6956470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.